VBI Vaccines Inc.
VBIV
Price:
$0.0653
Market Cap:
$1.87M
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP vaccines that mimic the presentation of viruses to elicit a human immune system. Its lead eVLP program candidates include VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study; and VBI-1501, a prophylact...[Read more]
Industry
Biotechnology
IPO Date
2010-04-26
Stock Exchange
NASDAQ
Ticker
VBIV
The ROE as of September 2024 (TTM) for VBI Vaccines Inc. (VBIV) is -1081.80%
According to VBI Vaccines Inc.’s latest financial reports and current stock price. The company's current ROE is -1081.80%. This represents a change of 1.41% compared to the average of -71.57% of the last 4 quarters.
VBI Vaccines Inc. (VBIV) Historical ROE (quarterly & annually)
How has VBIV ROE performed in the past?
The mean historical ROE of VBI Vaccines Inc. over the last ten years is -178.41%. The current -1081.80% ROE has changed 506.36% with respect to the historical average. Over the past ten years (40 quarters), VBIV's ROE was at its highest in in the March 2024 quarter at 327.42%. The ROE was at its lowest in in the June 2023 quarter at -510.73%.
Average
-178.41%
Median
-54.77%
Minimum
-1233.37%
Maximum
-5.68%
VBI Vaccines Inc. (VBIV) ROE by Quarter and Year
Discovering the peaks and valleys of VBI Vaccines Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 940.19%
Maximum Annual ROE = -5.68%
Minimum Annual Increase = -56.45%
Minimum Annual ROE = -1233.37%
| Year | ROE | Change |
|---|---|---|
| 2023 | -1233.37% | 461.45% |
| 2022 | -219.68% | 335.07% |
| 2021 | -50.49% | 83.35% |
| 2020 | -27.54% | -56.45% |
| 2019 | -63.23% | -2.44% |
| 2018 | -64.81% | 99.09% |
| 2017 | -32.55% | 17.46% |
| 2016 | -27.71% | -53.06% |
| 2015 | -59.04% | 940.19% |
| 2015 | -5.68% | 49.61% |
VBI Vaccines Inc. (VBIV) Average ROE
How has VBIV ROE performed in the past?
The current ROE of VBI Vaccines Inc. (VBIV) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-501.18%
5-year avg
-318.86%
10-year avg
-178.41%
VBI Vaccines Inc. (VBIV) ROE vs. Peers
How is VBIV’s ROE compared to its peers?
VBI Vaccines Inc.’s ROE is less than Tonix Pharmaceuticals Holding Corp. (0%), greater than Onconova Therapeutics, Inc. (-158.27%), greater than Jaguar Health, Inc. (-144.95%), greater than Vaxart, Inc. (-354.93%), greater than Allogene Therapeutics, Inc. (-114.19%), greater than Anixa Biosciences, Inc. (-53.76%), greater than Akero Therapeutics, Inc. (-52.41%), greater than Ardelyx, Inc. (-29.56%), greater than iBio, Inc. (-39.73%), greater than GeoVax Labs, Inc. (-147.88%), greater than Ocugen, Inc. (-852.58%), greater than Aurinia Pharmaceuticals Inc. (-139.20%), greater than Gritstone bio, Inc. (-13.48%), greater than BridgeBio Pharma, Inc. (-328.51%), less than Annovis Bio, Inc. (38.59%), less than ImmunoGen, Inc. (2.78%), greater than null (-21.97%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $3.25M | |
| -158.27% | $20.90M | |
| -144.95% | $10.26M | |
| -354.93% | $216.11M | |
| -114.19% | $576.10M | |
| -53.76% | $107.80M | |
| -52.41% | $1.88B | |
| -29.56% | $1.46B | |
| -39.73% | $16.69M | |
| -147.88% | $23.10M | |
| -852.58% | $336.79M | |
| -139.20% | $1.03B | |
| -13.48% | $65.92M | |
| -328.51% | $4.91B | |
| 38.59% | $104.17M | |
| 2.78% | $8.73B | |
| -21.97% | $0 |
Build a custom stock screener for VBI Vaccines Inc. (VBIV) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VBI Vaccines Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
VBI Vaccines Inc. (VBIV) and other stocks custom spreadsheet templates
The easiest way to analyze a company like VBI Vaccines Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is VBI Vaccines Inc.'s ROE?
How is the ROE calculated for VBI Vaccines Inc. (VBIV)?
What is the highest ROE for VBI Vaccines Inc. (VBIV)?
What is the 3-year average ROE for VBI Vaccines Inc. (VBIV)?
What is the 5-year average ROE for VBI Vaccines Inc. (VBIV)?
How does the current ROE for VBI Vaccines Inc. (VBIV) compare to its historical average?